Skip to content

Cognitive-behavioural treatment for adolescents with PTSD and SUD

Cognitive-behavioural treatment for adolescents with PTSD and SUD - CANSAS 2.B

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004530
Enrollment
74
Registered
2013-01-15
Start date
2013-01-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance use disorders (SUD) ICD-10 F10-19 Mental and behavioural disorders due to psychoactive substance use (excluding tobacco) F43.1

Interventions

Group 1: Seeking Safety: Interventiongroup: Cognitive-behavioural treatment. Participants will receive 12 weekly groupsessions (90 min. each) in open-enrollment groups comprising 4-8 patients. Introdu

Sponsors

Universitätsklinikum Hamburg-Eppendorf Deutsches Zentrum für Suchtfragen des Kindes- unhd Jugendalters
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
14 Years to 17 Years

Inclusion criteria

Inclusion criteria: female gender, age 14–17, able to follow verbal and written instructions, diagnosis of PTSD (at least „Partial PTSD” [e.g. Schützwohl & Maercker, 1999]: DSMIV criteria A, B, E and either criterion C or D SUD = at least hazardous substance use

Exclusion criteria

Exclusion criteria: intravenous drug use, actual psychosis, organic mental disorder, mental retardation, characteristics interfering with completion of therapy (e.g. impending incarceration).

Design outcomes

Primary

MeasureTime frame
PTBS-symptoms instruments: standardised assessment: Kinder-DIPS self-administered questionnaire: UCLA PTSD INDEX for DSM-IV - adolescent form, TSC-C measures: T0: baseline, T1: end of therapy 14 weeks later, T2: 3 months follow-up

Secondary

MeasureTime frame
(a) substance use instruments: Interview: ASI-Lite, Euro-ADAD Section D, SKID-I (b) substance use- and trauma-related cognitions instruments: self-administered questionnaires: WAS, BSU measures: T0: baseline, T1: end of therapy 14 weeks later, T2: 3 months follow-up

Countries

Germany

Contacts

Public ContactAndrea Haevelmann

Universitätsklinikum Hamburg-Eppendorf Deutsches Zentrum für Suchtfragen des Kindes- und Jugendalters

a.haevelmann@uke.de040741055259

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026